Whether or not AGT inactivators that specifically target tumor cells [158,159,160] or other means of attenuating AGT activity, for example, tumor treating fields [161], alkylating drug combinations [162], or antisense strategies [163], will prove to be more successful remains to be seen. Here, AGT is linked to neoplasm.